Previously used VIV were used because there was no alternative. Either the patients die or you put a less than optimal valve in. With the arrival of DuAVR, clearly the 2 cardiologist in Canada disagree with your view that there is an alternative.
Expression the same opinion over and over does not necessarily make it right. I would back the views of the two canadian cardiologist anytime over yours with repect.
Ann: Exceptional Results in Second Valve-in-Valve Case, page-17
-
- There are more pages in this discussion • 26 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.49 |
Change
-0.190(1.21%) |
Mkt cap ! $335.8M | |||
| Open | High | Low | Value | Volume |
| $15.70 | $15.94 | $15.03 | $209.5K | 13.39K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 890 | $15.09 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.50 | 98 | 2 |
View Market Depth
| Last trade - 11.51am 19/08/2024 (20 minute delay) ? |
| AVR (ASX) Chart |